1. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation;Hutter;N Engl J Med,2009
2. Persaud D, Gay H, Ziemniak C, et al. Functional HIV cure after very early ART of an infected infant. 20th Conference on Retroviruses and Opportunistic Infections. Atlanta, GA; March 3–6, 2013. 48LB (abstr).
3. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy;Archin;Nature,2012
4. Elliott J, Solomon A, Wightman F, et al. The safety and effect of multiple doses of vorinostat on HIV transcription in HIV+ patients receiving cART. 20th Conference on Retroviruses and Opportunistic Infections. Atlanta, GA; March 3–6, 2013. 50LB (abstr).
5. Tolstrup M. Cyclic panobinostat (LBH 589) dosing in HIV-1 patients: findings from the CLEAR trial. Towards an HIV Cure Symposium. Kuala Lumpur, Malaysia; June 30–July 3, 2013.